Hot Features
Premium
Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Período:
Tipo de Línea:
| Volume | 12,487 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 3.00 | Mínimo Máximo |
|||||
| Minimo del Dia | 2.8301 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| GT Biopharma Inc | GTBP | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.11 | -3.67% | 2.89 | 23:00:06 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 2.97 | 2.8301 | 3.00 | 2.89 | 3.00 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 146 | 12,487 | US$ 2.95 | US$ 36,806 | - | 2.61 - 14.37 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 17:45:35 | 10 | US$ 2.83 | USD |
Información Financiera GT Biopharma Inc GTBP
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 4.1M | 1.38M | - | 0 | -7.6M | -5.50 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre GT Biopharma Inc GTBP
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 13/6/2024 | 15:14 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 07/6/2024 | 16:25 | Edgar (US Regulatory) | Form 8-K - Current report |
| 23/5/2024 | 19:31 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 23/5/2024 | 05:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 23/5/2024 | 05:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15/5/2024 | 16:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 14/2/2024 | 13:46 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 01/2/2024 | 11:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 21/12/2023 | 14:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04/12/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 06/11/2023 | 16:25 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 06/11/2023 | 16:23 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
Histórico de Datos GTBP
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.26 | 3.3299 | 2.61 | 2.98 | 77,170 | -0.37 | -11.35% |
| 1 Month | 3.32 | 10.6599 | 2.61 | 7.22 | 4,517,341 | -0.43 | -12.95% |
| 3 Months | 4.62 | 10.6599 | 2.61 | 7.21 | 1,487,137 | -1.73 | -37.45% |
| 6 Months | 6.75 | 10.6599 | 2.61 | 7.18 | 739,084 | -3.86 | -57.19% |
| 1 Year | 10.20 | 14.37 | 2.61 | 7.65 | 513,873 | -7.31 | -71.67% |
| 3 Years | 541.50 | 591.993 | 2.61 | 68.02 | 306,188 | -538.61 | -99.47% |
| 5 Years | 165.00 | 591.993 | 2.61 | 109.21 | 336,889 | -162.11 | -98.25% |
